MedExplorer is returning with a new site shortly.
EVOXAC
http://www.evoxac.com
EVOXACTM (cevimeline HCI) 30 mg capsules, introduced in 2000, is a product marketed and distributed in the United States by Daiichi Pharmaceutical Corporation. This product is FDA approved for the treatment of dry mouth symptoms in patients with Sjögren's (SHOW-grins) syndrome.
Back to Previous Page
Choose Your Letter:
[ A | B | C | D | E | F | G | H
| I | J | K | L | M | N | O | P
| Q | R | S | T | U | V | W | X
| Y | Z ]
© 1996 - 2025 - MedExplorer. All Rights Reserved.
Reproduction in whole or in
part in any form or medium without express written permission of MedExplorer Inc. is
prohibited. MedExplorer and the MedExplorer logos are trademarks of MedExplorer Inc.
MedExplorer assumes no liability for any information provided through this website or
respective links. Anyone using this information does so of their own volition and at
their own risk. Should you require information in regards to a specific medical condition,
please contact your family physician or other appropriate physician. Specific Medical Advice
will not be provided and MedExplorer urges you to visit a qualified physician and/or in the
event of an emergency contact your local emergency services or seek immediate care at an
emergency department.